Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
NCT02524340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 465
Last updated 2019-09-23
Summary
The best treatment plan for Juvenile Idiopathic Arthritis (JIA) is often complicated. Patients and clinicians often don't know what is the best treatment strategy for a given patient at a given time. The purpose of this study is to develop a method to analyze data in situations where the treatment and disease state change over time. The researchers will develop a web-based package that will use the methods developed in this study. The package will be easy to use and allow dissemination of the methods to the public.
Conditions
- Juvenile Idiopathic Arthritis
Sponsors & Collaborators
-
Patient-Centered Outcomes Research Institute
collaborator OTHER -
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Bin Huang, PhD · Children's Hospital Medical Center, Cincinnati
Eligibility
- Min Age
- 1 Year
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
NCT03780959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission
NCT06618937 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS
NCT02311842 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
NCT04585711 ·Status: WITHDRAWN ·Phase: PHASE1
-
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430 ·Status: COMPLETED ·Phase: PHASE4
-
Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study
NCT02915354 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
NCT01513902 ·Status: COMPLETED ·Phase: PHASE1
-
Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis
NCT00000429 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
NCT00891046 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
NCT03006991 ·Status: UNKNOWN
-
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
NCT02418442 ·Status: RECRUITING
-
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
NCT02094326 ·Status: COMPLETED
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 ·Status: ACTIVE_NOT_RECRUITING
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
NCT00688545 ·Status: TERMINATED
-
Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients
NCT02997605 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Clinical and Medico-economic Impact of SinnoTest® in Patients With Rheumatoid Arthritis
NCT04117165 ·Status: WITHDRAWN ·Phase: NA
-
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
NCT01783015 ·Status: TERMINATED ·Phase: PHASE4
-
Advanced Therapeutics in Rheumatoid Arthritis (RA)
NCT03976245 ·Status: RECRUITING ·Phase: PHASE4
-
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
NCT01287715 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
NCT03265132 ·Status: TERMINATED ·Phase: PHASE3